249 related articles for article (PubMed ID: 8984377)
1. [Riluzole treatment in amyotrophic lateral sclerosis].
Wokke JH
Ned Tijdschr Geneeskd; 1996 Nov; 140(46):2265-8. PubMed ID: 8984377
[No Abstract] [Full Text] [Related]
2. Riluzole for amyotrophic lateral sclerosis.
Med Lett Drugs Ther; 1995 Dec; 37(963):113-4. PubMed ID: 7500908
[No Abstract] [Full Text] [Related]
3. Rilutek (Riluzole) may extend survival in amyotrophic lateral sclerosis.
J Neurosci Nurs; 1996 Aug; 28(4):275. PubMed ID: 8880606
[No Abstract] [Full Text] [Related]
4. Riluzole for amyotrophic lateral sclerosis.
Drug Ther Bull; 1997 Feb; 35(2):11-2. PubMed ID: 9282413
[TBL] [Abstract][Full Text] [Related]
5. [Riluzole for everybody or for nobody].
Martí-Fàbregas J
Neurologia; 1996 Jan; 11(1):44-5. PubMed ID: 8714179
[No Abstract] [Full Text] [Related]
6. [Amyotrophic lateral sclerosis. Fatal diagnosis -- how still can be helped?].
Stiefelhagen P
MMW Fortschr Med; 2004 Nov; 146(47):16. PubMed ID: 15624649
[No Abstract] [Full Text] [Related]
7. [Neuroprotective therapy for amyotrophic lateral sclerosis (ALS)].
Yanagisawa N; Shindo M
Rinsho Shinkeigaku; 1996 Dec; 36(12):1329-30. PubMed ID: 9128396
[TBL] [Abstract][Full Text] [Related]
8. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
Miller RG; Mitchell JD; Lyon M; Moore DH
Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
[TBL] [Abstract][Full Text] [Related]
9. Riluzole and ALS therapy.
Hugon J
Wien Med Wochenschr; 1996; 146(9-10):185-7. PubMed ID: 8873431
[TBL] [Abstract][Full Text] [Related]
10. Riluzole in amyotrophic lateral sclerosis.
Rogawski MA
N Engl J Med; 1994 Jul; 331(4):273; author reply 273-4. PubMed ID: 8015581
[No Abstract] [Full Text] [Related]
11. What has changed with riluzole?
Meininger V; Lacomblez L; Salachas F
J Neurol; 2000 Dec; 247():19-22. PubMed ID: 11200701
[TBL] [Abstract][Full Text] [Related]
12. Effect of riluzole (Rilutek) treatment on plasma amino acid percentages in amyotrophic lateral sclerosis patients.
Iłzecka J; Stelmasiak Z; Solski J; Wawrzycki S; Szpetnar M
Neurol Sci; 2003 Nov; 24(4):290-2. PubMed ID: 14658053
[TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of treatment with riluzole].
Meininger V; Lacomblez L; Bensimon G
Rev Neurol (Paris); 1997 Oct; 153(10):539-40. PubMed ID: 9684016
[No Abstract] [Full Text] [Related]
14. [Glutamate antagonist].
Shindo M
No To Shinkei; 1998 Jul; 50(7):597-605. PubMed ID: 9739517
[No Abstract] [Full Text] [Related]
15. Riluzole in amyotrophic lateral sclerosis.
Murphy JR
N Engl J Med; 1994 Jul; 331(4):273; author reply 273-4. PubMed ID: 8015580
[No Abstract] [Full Text] [Related]
16. Amyotrophic lateral sclerosis, excitotoxicity and riluzole.
Obrenovitch TP
Trends Pharmacol Sci; 1998 Jan; 19(1):9-11. PubMed ID: 9509893
[No Abstract] [Full Text] [Related]
17. [The advance in the research and therapeutic trials of amyotrophic lateral sclerosis].
Moriwaka F; Tashiro K
Rinsho Shinkeigaku; 2000 Dec; 40(12):1258-60. PubMed ID: 11464472
[TBL] [Abstract][Full Text] [Related]
18. A placebo arm is not always necessary in clinical trials of amyotrophic lateral sclerosis.
Gordon PH
Muscle Nerve; 2009 Jun; 39(6):858-60. PubMed ID: 19382169
[TBL] [Abstract][Full Text] [Related]
19. Riluzole for ALS: what is the evidence?
Miller R
Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):135. PubMed ID: 13129798
[No Abstract] [Full Text] [Related]
20. Practice advisory on the treatment of amyotrophic lateral sclerosis with riluzole: report of the Quality Standards Subcommittee of the American Academy of Neurology.
Neurology; 1997 Sep; 49(3):657-9. PubMed ID: 9305318
[No Abstract] [Full Text] [Related]
[Next] [New Search]
